In the treatment of unresectable or metastatic Merkel cell carcinoma, immune checkpoint inhibitors have activity and tolerability.
Ann W. Silk, MD, MS
Advertisement
Articles by Ann W. Silk, MD, MS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Lirafugratinib for Pretreated, Locally Advanced or Metastatic Cholangiocarcinoma
2
Dr Mayer on the FDA Approval of Camizestrant for ESR1-Mutated Breast Cancer
3
Dr Kuykendall on the Significance of the FDA Approval of Rusfertide for Polycythemia Vera
4